目次

Table of Contents

Chapter 1. CRISPR-based POC Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product
1.1.1.2. Technology Segment
1.1.1.3. Application Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. CRISPR-based POC Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Product
2.3. Technology Snapshot
2.4. Application Snapshot
2.5. End Use Snapshot
2.6. Competitive Landscape Snapshot

Chapter 3. CRISPR-based POC Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Decentralized and accessible diagnostics
3.4.2. Rising global burden of infectious and genetic diseases
3.4.3. Growing need to combat antimicrobial resistance (AMR)
3.5. Market Restraint Analysis
3.5.1. Regulatory and clinical validation barriers
3.5.2. Manufacturing scalability and cost constraints
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis

Chapter 4. CRISPR-based POC Diagnostics Market: Product Estimates & Trend Analysis
4.1. CRISPR-based POC Diagnostics Market: Product Movement Analysis
4.2. Instruments/Devices
4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Assay Kits and Reagents
4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Software and Connectivity Platforms
4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. CRISPR-based POC Diagnostics Market: Technology Estimates & Trend Analysis
5.1. CRISPR-based POC Diagnostics Market: Technology Movement Analysis
5.2. Cas9-Based
5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Cas12-Based (DETECTR Technology)
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Cas13-Based (SHERLOCK Technology)
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Other Emerging Cas Systems
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. CRISPR-based POC Diagnostics Market: Application Estimates & Trend Analysis
6.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
6.2. Infectious Disease Diagnostics
6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Genetic Disorder Testing
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Oncology Diagnostics
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Antimicrobial Resistance (AMR) Testing
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Other Applications
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. CRISPR-based POC Diagnostics Market: End Use Estimates & Trend Analysis
7.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
7.2. Hospitals and Clinics
7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Diagnostic Laboratories
7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Homecare / At-Home Testing
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Others
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. CRISPR-based POC Diagnostics Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America CRISPR-based POC Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Reimbursement Scenario
8.2.4.5. Competitive Scenario
8.3. Europe
8.3.1. Europe CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.2. UK
8.3.2.1. UK CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. Germany
8.3.3.1. Germany CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. Spain
8.3.4.1. Spain CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. France
8.3.5.1. France CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. Italy
8.3.6.1. Italy CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia-Pacific CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. China
8.4.3.1. China CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. India
8.4.4.1. India CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. Thailand
8.4.6.1. Thailand CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. Australia
8.4.7.1. Australia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. Argentina
8.5.3.1. Argentina CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.6. Middle East & Africa
8.6.1. Middle East & Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Key Company Market Share Analysis, 2024
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. Mammoth Biosciences, Inc.
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. OraSure Technologies, Inc. (Sherlock Biosciences)
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Caspr Biotech
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. GenScript
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Integrated DNA Technologies, Inc.
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Synthego
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Revvity Discovery Limited
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Twist Bioscience
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Crisprbits
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Danaher Corporation (Cepheid)
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global CRISPR-based POC Diagnostics Market, By Region, 2021 - 2033 (USD Million)
Table 4 Global CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 5 Global CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 6 Global CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 7 Global CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 8 North America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
Table 9 North America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 10 North America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 11 North America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 12 North America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 13 U.S. CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 14 U.S. CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 15 U.S. CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 16 U.S. CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Canada CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 18 Canada CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 19 Canada CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 20 Canada CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 21 Mexico CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 22 Mexico CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 23 Mexico CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 24 Mexico CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Europe CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
Table 26 Europe CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 27 Europe CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 28 Europe CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 29 Europe CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 30 UK CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 31 UK CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 32 UK CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 33 UK CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 34 Germany CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 35 Germany CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 36 Germany CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 37 Germany CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 38 France CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 39 France CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 40 France CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 41 France CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Italy CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 43 Italy CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 44 Italy CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 45 Italy CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Spain CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 47 Spain CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 48 Spain CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 49 Spain CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 50 Sweden CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 51 Sweden CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 52 Sweden CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 53 Sweden CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Norway CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 55 Norway CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 56 Norway CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 57 Norway CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 58 Denmark CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 59 Denmark CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 60 Denmark CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 61 Denmark CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 64 Asia Pacific CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 65 Asia-Pacific CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 66 Asia Pacific CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 67 Japan CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 68 Japan CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 69 Japan CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 70 Japan CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 71 China CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 72 China CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 73 China CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 74 China CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 75 India CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 76 India CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 77 India CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 78 India CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 79 Australia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 80 Australia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 81 Australia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 82 Australia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 83 Thailand CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 84 Thailand CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 85 Thailand CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 86 Thailand CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 87 South Korea CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 88 South Korea CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 89 South Korea CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 90 South Korea CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 91 Latin America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
Table 92 Latin America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 93 Latin America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 94 Latin America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 95 Latin America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 96 Brazil CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 97 Brazil CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 98 Brazil CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 99 Brazil CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 100 Argentina CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 101 Argentina CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 102 Argentina CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 103 Argentina CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 104 Middle East & Africa CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
Table 105 Middle East & Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 106 Middle East & Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 107 Middle East & Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 109 South Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 110 South Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 111 South Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 112 South Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 117 UAE CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 118 UAE CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 119 UAE CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 120 UAE CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
Table 122 Kuwait CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
Table 123 Kuwait CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
Table 124 Kuwait CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global CRISPR-based POC diagnostics market - Key market driver analysis
Fig. 7 Global CRISPR-based POC diagnostics market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global CRISPR-based POC diagnostics market - Porter’s analysis
Fig. 10 Global CRISPR-based POC diagnostics market - PESTEL analysis
Fig. 11 Global CRISPR-based POC diagnostics market: Product outlook key takeaways
Fig. 12 Global CRISPR-based POC diagnostics market: Product movement analysis
Fig. 13 Instruments/devices market estimates, 2021 - 2033 (USD Million)
Fig. 14 Assay kits and reagents market estimates, 2021 - 2033 (USD Million)
Fig. 15 Software and connectivity platforms market estimates, 2021 - 2033 (USD Million)
Fig. 16 Global CRISPR-based POC diagnostics market: Technology outlook key takeaways
Fig. 17 Global CRISPR-based POC diagnostics market: Technology movement analysis
Fig. 18 Cas9-based market estimates, 2021 - 2033 (USD Million)
Fig. 19 Cas12-based (DETECTR technology) market estimates, 2021 - 2033 (USD Million)
Fig. 20 Cas13-based (SHERLOCK technology) market estimates, 2021 - 2033 (USD Million)
Fig. 21 Other emerging Cas systems market estimates, 2021 - 2033 (USD Million)
Fig. 22 Global CRISPR-based POC diagnostics market: Application outlook key takeaways
Fig. 23 Global CRISPR-based POC diagnostics market: Application movement analysis
Fig. 24 Infectious disease diagnostics market estimates, 2021 - 2033 (USD Million)
Fig. 25 Genetic disorder testing market estimates, 2021 - 2033 (USD Million)
Fig. 26 Oncology diagnostics market estimates, 2021 - 2033 (USD Million)
Fig. 27 Antimicrobial resistance (AMR) testing market estimates, 2021 - 2033 (USD Million)
Fig. 28 Other applications market estimates, 2021 - 2033 (USD Million)
Fig. 29 Global CRISPR-based POC diagnostics market: End Use outlook key takeaways
Fig. 30 Global CRISPR-based POC diagnostics market: End Use movement analysis
Fig. 31 Hospitals and clinics market estimates, 2021 - 2033 (USD Million)
Fig. 32 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
Fig. 33 Homecare / at-home testing market estimates, 2021 - 2033 (USD Million)
Fig. 34 Others market estimates, 2021 - 2033 (USD Million)
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Global CRISPR-based POC diagnostics market: Regional movement analysis
Fig. 37 North America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 38 U.S. CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 39 Canada CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 40 Mexico CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 41 Europe CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 42 UK CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 43 Germany CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 44 France CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 45 Spain CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 46 Italy CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 47 Denmark CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 48 Sweden CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 49 Norway CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 50 Asia Pacific CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 51 Japan CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 52 China CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 53 India CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 54 South Korea CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 55 Australia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 56 Thailand CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 57 Latin America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 58 Brazil CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 59 Argentina CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 60 Middle East & Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 61 South Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 62 Saudi Arabia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 63 UAE CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 64 Kuwait CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
Fig. 65 Strategy framework